The Ohio State University Wexner Medical Center is a multidisciplinary academic medical center located in Columbus, Ohio, United States, on the main campus of The Ohio State University.

There are 2,260 beds in Ohio State University Medical Center.

During the past decade, Ohio State University Medical Center conducted 509 clinical trials. In the 10-year time frame, 509 clinical trials started and 282 clinical trials were completed, i.e. on average, 55.4% percent of trials that started reached the finish line to date. In the past 5 years, 198 clinical trials started and 163 clinical trials were completed. i.e. 82.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ohio State University Medical Center" #1 sponsor was "Ohio State University" with 105 trials, followed by "National Cancer Institute (NCI)" with 41 trials sponsored, "Ohio State University Comprehensive Cancer Center" with 41 trials sponsored, "Boston Scientific Corporation" with 26 trials sponsored and "National Institute of Allergy and Infectious Diseases (NIAID)" with 26 trials sponsored. Other sponsors include 697 different institutions and companies that sponsored additional 408 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ohio State University Medical Center" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 24 trials as a collaborator, "Ohio State University" with 23 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 22 trials as a collaborator, "National Cancer Institute (NCI)" with 19 trials as a collaborator and "Medical University of South Carolina" with 17 trials as a collaborator. Other collaborators include 649 different institutions and companies that were collaborators in the rest 381 trials.

According to Clinical.Site data, the most researched conditions in "Ohio State University Medical Center" are "Heart Failure" (24 trials), "Pulmonary Arterial Hypertension" (22 trials), "HIV Infections" (21 trials), "Breast Cancer" (14 trials) and "Coronary Artery Disease" (14 trials). Many other conditions were trialed in "Ohio State University Medical Center" in a lesser frequency.

Most popular intervention types in "Ohio State University Medical Center" are "Drug" (508 trials), "Device" (192 trials), "Other" (161 trials), "Procedure" (83 trials) and "Biological" (69 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (143 trials), "laboratory biomarker analysis" (32 trials), "pharmacological study" (25 trials), "placebo" (14 trials) and "Dexamethasone" (9 trials). Other intervention names were less common.

The vast majority of trials in "Ohio State University Medical Center" are 867 trials for "All" genders, 52 trials for "Female" genders and 12 trials for "Male" genders.

Currently, there are 276 active trials in "Ohio State University Medical Center". 3 are not yet recruiting, 164 are recruiting, 106 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 480 completed trials in Ohio State University Medical Center, 4 suspended trials, and 133 terminated clinical trials to date.

Out of the total trials that were conducted in Ohio State University Medical Center, 134 "Phase 1" clinical trials were conducted, 216 "Phase 2" clinical trials and 209 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 39 trials, and there were also 232 trials that are defined as “Not Applicable".